Search by Drug Name or NDC

    NDC 65862-0697-01 Venlafaxine Hydrochloride 150 mg/1 Details

    Venlafaxine Hydrochloride 150 mg/1

    Venlafaxine Hydrochloride is a ORAL CAPSULE, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Aurobindo Pharma Limited. The primary component is VENLAFAXINE HYDROCHLORIDE.

    Product Information

    NDC 65862-0697
    Product ID 65862-697_90b993cd-e9aa-4b60-8824-dc08bbb7154b
    Associated GPIs 58180090107050
    GCN Sequence Number 046405
    GCN Sequence Number Description venlafaxine HCl CAP ER 24H 150 MG ORAL
    HIC3 H7C
    HIC3 Description SEROTONIN-NOREPINEPHRINE REUPTAKE-INHIB (SNRIS)
    GCN 16818
    HICL Sequence Number 008847
    HICL Sequence Number Description VENLAFAXINE HCL
    Brand/Generic Generic
    Proprietary Name Venlafaxine Hydrochloride
    Proprietary Name Suffix n/a
    Non-Proprietary Name Venlafaxine Hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 150
    Active Ingredient Units mg/1
    Substance Name VENLAFAXINE HYDROCHLORIDE
    Labeler Name Aurobindo Pharma Limited
    Pharmaceutical Class Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA200834
    Listing Certified Through 2024-12-31

    Package

    NDC 65862-0697-01 (65862069701)

    NDC Package Code 65862-697-01
    Billing NDC 65862069701
    Package 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65862-697-01)
    Marketing Start Date 2011-11-23
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.15158
    Pricing Unit EA
    Effective Date 2022-11-23
    NDC Description VENLAFAXINE HCL ER 150 MG CAP
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2022-11-23
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis